Response to Hajifathalian and Katz Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors

Am J Gastroenterol. 2020 Nov;115(11):1922-1923. doi: 10.14309/ajg.0000000000000993.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • Proton Pump Inhibitors* / adverse effects
  • Risk Factors
  • SARS-CoV-2

Substances

  • Proton Pump Inhibitors